Contact
searchSearch
HMP Global
Login
News
Using Postmenopausal Bleeding to Detect Endometrial Cancer
09/19/2020
Evaluating women for postmenopausal bleeding aids in the early detection of, and implementation of prevention strategies for, endometrial cancer.
Evaluating women for postmenopausal bleeding aids in the early detection of, and implementation of prevention strategies for, endometrial cancer.
Evaluating women for...
09/19/2020
Oncology
News
Early Diagnosis of Ovarian Cancer Possible With Papanicolaou Tests
08/26/2020
Tumor-specific TP53 variants were detected in Papanicolaou tests for routine cervical cancer screenings up to 6 years before ovarian cancer diagnosis.
Tumor-specific TP53 variants were detected in Papanicolaou tests for routine cervical cancer screenings up to 6 years before ovarian cancer diagnosis.
Tumor-specific TP53 variants...
08/26/2020
Oncology
News
Cancer Cells in Endometrial Cysts Could Lead to Earlier Ovarian Cancer Detection
08/17/2020
Researchers have found that EAOC often occurs within 36 months of follow-up for endometrial cysts, suggesting that cancer cells are in endometrial cysts.
Researchers have found that EAOC often occurs within 36 months of follow-up for endometrial cysts, suggesting that cancer cells are in endometrial cysts.
Researchers have found that EAOC...
08/17/2020
Oncology
News
Oral Apixaban Preferable for Preventing Postsurgery VTE in Patients With Gynecologic Cancer
08/10/2020
For patients undergoing surgery for gynecologic cancer, oral apixaban is easier and less painful to administer than subcutaneous enoxaparin.
For patients undergoing surgery for gynecologic cancer, oral apixaban is easier and less painful to administer than subcutaneous enoxaparin.
For patients undergoing surgery...
08/10/2020
Oncology
News
Molecular Classification Has Strong Prognostic Value in High-Risk Endometrial Cancer
08/07/2020
Molecular classification has strong prognostic value in high-risk endometrial cancer and should be incorporated in future trials to target subgroups of patients.
Molecular classification has strong prognostic value in high-risk endometrial cancer and should be incorporated in future trials to target subgroups of patients.
Molecular classification has...
08/07/2020
Oncology
News
Long-Term Cardiovascular Adverse Events Among Survivors of Endometrial Cancer
05/08/2020
Survivors of uterine cancer are at higher risk of experiencing cardiovascular problems years after treatment.
Survivors of uterine cancer are at higher risk of experiencing cardiovascular problems years after treatment.
Survivors of uterine cancer are...
05/08/2020
Oncology

Recent News

News
Using Postmenopausal Bleeding to Detect Endometrial Cancer
09/19/2020
Evaluating women for postmenopausal bleeding aids in the early detection of, and implementation of prevention strategies for, endometrial cancer.
Evaluating women for postmenopausal bleeding aids in the early detection of, and implementation of prevention strategies for, endometrial cancer.
Evaluating women for...
09/19/2020
Oncology
News
Early Diagnosis of Ovarian Cancer Possible With Papanicolaou Tests
08/26/2020
Tumor-specific TP53 variants were detected in Papanicolaou tests for routine cervical cancer screenings up to 6 years before ovarian cancer diagnosis.
Tumor-specific TP53 variants were detected in Papanicolaou tests for routine cervical cancer screenings up to 6 years before ovarian cancer diagnosis.
Tumor-specific TP53 variants...
08/26/2020
Oncology
News
Cancer Cells in Endometrial Cysts Could Lead to Earlier Ovarian Cancer Detection
08/17/2020
Researchers have found that EAOC often occurs within 36 months of follow-up for endometrial cysts, suggesting that cancer cells are in endometrial cysts.
Researchers have found that EAOC often occurs within 36 months of follow-up for endometrial cysts, suggesting that cancer cells are in endometrial cysts.
Researchers have found that EAOC...
08/17/2020
Oncology
News
Oral Apixaban Preferable for Preventing Postsurgery VTE in Patients With Gynecologic Cancer
08/10/2020
For patients undergoing surgery for gynecologic cancer, oral apixaban is easier and less painful to administer than subcutaneous enoxaparin.
For patients undergoing surgery for gynecologic cancer, oral apixaban is easier and less painful to administer than subcutaneous enoxaparin.
For patients undergoing surgery...
08/10/2020
Oncology
News
Molecular Classification Has Strong Prognostic Value in High-Risk Endometrial Cancer
08/07/2020
Molecular classification has strong prognostic value in high-risk endometrial cancer and should be incorporated in future trials to target subgroups of patients.
Molecular classification has strong prognostic value in high-risk endometrial cancer and should be incorporated in future trials to target subgroups of patients.
Molecular classification has...
08/07/2020
Oncology

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use